DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells. - Wikidata - awgldk - TriplyDB

DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells.

DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells.

http://www.wikidata.org/entity/Q37675217

about

High expression of dedicator of cytokinesis 1 (DOCK1) confers poor prognosis in acute myeloid leukemia.DOCK2: A novel FLT3/ITD leukemia drug target.

P2860

Q42700810-380D0C1B-1397-4351-A684-29916D0E8AEB Q46650820-5F4A48C2-0BBB-40CD-990A-686CA465C5EF

P2860

DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells.

http://www.wikidata.org/entity/Q37675217

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells.

@en

DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells.

@nl

type

label

DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells.

@en

DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells.

@nl

prefLabel

DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells.

@en

DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells.

@nl

P1433

Q37675217-E8D2883E-C71F-45A2-8332-1B8D1ED0E951

P1476

Q37675217-2FB241D3-554E-4752-A874-349A547CE6A0

P2093

Q37675217-29604C21-6417-442A-B69C-9A74F7A730EC

Q37675217-49778282-FC14-4FD1-ACF8-23E8369A21D8

Q37675217-651140EA-A57C-4206-8AB2-B264741A90B7

Q37675217-BE1932A8-9F6C-4313-BF62-C298963ED5F6

Q37675217-C36661B5-6A27-407B-9A0D-E99167730DC9

P2860

Q37675217-076CA717-EDCC-4ECA-BC77-6A6325102E60

Q37675217-09180693-F717-4EB6-A13D-2BDE391A1216

Q37675217-0E8A51F7-1DD2-4722-AFC2-3CEED90B0985

Q37675217-1DBB2DE5-EC7E-466D-B7C7-A419F7F1D323

Q37675217-1E6176FA-08FD-45F4-8E10-56A2A505DD2F

Q37675217-25364CC1-50FE-4827-9B49-1D0B7917C372

Q37675217-29F43862-7771-4665-A85D-8010B4D4E406

Q37675217-32844B96-A8A3-4835-9593-4D66AE5905CC

Q37675217-37C37F93-9099-4AE1-9E3B-9C83CAE978E5

Q37675217-39718E14-A2F9-42DF-BB06-E8BBC189E7C1

P2888

Q37675217-97438E31-F813-4CE6-8A04-E552C45BDC21

P304

Q37675217-8E6C666E-5793-4F88-9CBC-A347B094EF7A

P31

Q37675217-2C228304-0A98-4BD0-B566-3DF7B7FEBC5A

P356

Q37675217-10D9D796-4150-46DC-BE66-74610E0D060D

P433

Q37675217-90069971-DD70-4ABD-9FA2-0692AB77EA4F

P478

Q37675217-FE83E8F1-5FF3-418E-A520-E98F2963CB2E

P577

Q37675217-A25BDBD6-3D38-49E5-91A1-A57D92C0ED91

P698

Q37675217-44C40A5D-AE90-4682-BD9D-F427741C356C

P921

Q37675217-9A1F6389-C8B2-46EE-9CC9-2CEA4E469DC8

P932

Q37675217-74D8D81D-A6F8-4CCE-B179-4BA7224D78DF

P356

P1433

P1476

DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells.

@en

P2093

A S Duffield

http://www.w3.org/2001/XMLSchema#string

D Small

http://www.w3.org/2001/XMLSchema#string

L Li

http://www.w3.org/2001/XMLSchema#string

M Hamaker

http://www.w3.org/2001/XMLSchema#string

M Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias

Approaches of targeting Rho GTPases in cancer drug discovery

Mutationally activated Rho GTPases in cancer

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia.

Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.

Rho GTPases in cell biology

Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome

Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration

P2888

P304

688-696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2016.284

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27748370

http://www.w3.org/2001/XMLSchema#string

P921

P932

5332301

http://www.w3.org/2001/XMLSchema#string